IP Verse

Oral Pharmaceutical Formulation - EP2994108

The patent EP2994108 was granted to Siegfried on Oct 28, 2020. The application was originally filed on May 6, 2014 under application number EP14721880A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2994108

SIEGFRIED
Application Number
EP14721880A
Filing Date
May 6, 2014
Status
Granted And Under Opposition
Sep 25, 2020
Publication Date
Oct 28, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EVONIK OPERATIONSJul 16, 2021EVONIK PATENT ASSOCIATIONWITHDRAWN

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP1964549
DESCRIPTIONWO2007036632
DESCRIPTIONWO2008015220
DESCRIPTIONWO2010046933
INTERNATIONAL-SEARCH-REPORTEP1157690
INTERNATIONAL-SEARCH-REPORTEP1759692
INTERNATIONAL-SEARCH-REPORTUS2008248111
INTERNATIONAL-SEARCH-REPORTUS6106861
INTERNATIONAL-SEARCH-REPORTWO2008015220
INTERNATIONAL-SEARCH-REPORTWO2010046933
OPPOSITIONUS2008248111
OPPOSITIONWO02067906
OPPOSITIONWO2004087096
OPPOSITIONWO2004096182
OPPOSITIONWO2011012335

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- "Advances in Delivery Science and Technology", CLIVE G. WILSON; PATRICK J. CROWLEY, Controlled Release in Oral Drug Delivery, (2011), page 269
DESCRIPTION- WU ET AL., "Predicting Drug Disposition via Application of BCS: Transport/Absorption/Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System", PHARMACEUTICAL RESEARCH, (200501), vol. 22, no. 1, doi:doi:10.1007/s11095-004-1189-z, XP019370686
OPPOSITION- Annamalai Muthaiah, Et Al, "EUDRAGIT® Application Guidelines. 11th edition. Chapter 7 Taste Masking Formulations", Evonik Röhm GmbH, (20090901), pages 1 - 48, XP055828428

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents